ERRα regulates breast cancer cell proliferation in in vitro and in vivo models and genetic deletion of ERRα delays tumour formation in a transgenic model of HER2-induced mammary tumourigenesis [34]. The gene discussed is ESRRA; the disease is breast cancer.